Suppr超能文献

AlphaCor病例:比较结果

AlphaCor cases: comparative outcomes.

作者信息

Hicks Celia R, Crawford Geoffrey J, Tan Donald T, Snibson Grant R, Sutton Gerard L, Downie Nicholas, Gondhowiardjo Tjahjono D, Lam Dennis S-C, Werner Liliana, Apple David, Constable Ian J

机构信息

Lionas Eye Institute of Western Australia, Australia.

出版信息

Cornea. 2003 Oct;22(7):583-90. doi: 10.1097/00003226-200310000-00001.

Abstract

PURPOSE

To describe clinical outcomes after a novel type of corneal surgery, implantation of an artificial cornea, AlphaCor , and to evaluate outcomes in comparison with alternative keratoprostheses and high-risk grafts.

METHODS

Case reports and data from a noncontrolled clinical trial and a literature review.

RESULTS

The probability of AlphaCor retention to 1 year is 80%. Postoperative best corrected visual acuity ranges from Perception Light to 20/30. The most significant complications are stromal melts and optic depositions, for both of which the main risk factors have been identified. Complications can be managed without loss of the eye.

CONCLUSION

Results from the clinical trial period have helped to determine the indications and risk factors for AlphaCor surgery and to refine surgical techniques. Continued monitoring of outcomes as the series increases will allow a more accurate determination of comparative outcomes. The series provides preliminary evidence that AlphaCor may have a lower incidence of complications than traditional keratoprostheses and may prove to be preferable to a donor graft in high-risk cases.

摘要

目的

描述一种新型角膜手术(植入人工角膜AlphaCor)后的临床结果,并与其他角膜移植假体和高风险移植进行比较,评估其结果。

方法

病例报告、非对照临床试验数据及文献综述。

结果

AlphaCor保留至1年的概率为80%。术后最佳矫正视力范围从光感至20/30。最显著的并发症是基质溶解和光学沉积物,且已确定了两者的主要危险因素。并发症可得到处理而不致失明。

结论

临床试验阶段的结果有助于确定AlphaCor手术的适应证和危险因素,并完善手术技术。随着病例数增加持续监测结果将能更准确地确定比较结果。该病例系列提供了初步证据,表明AlphaCor的并发症发生率可能低于传统角膜移植假体,在高风险病例中可能比供体移植更具优势。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验